Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
The New England journal of medicine.
Times cited: 2033
- Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
AJR. American journal of roentgenology.
Times cited: 35